Antibiotics are meant to kill living things (bacteria). Viruses, on the other hand, we are not sure if they would classify as living. Viruses change the meaning of "life" if we consider them alive. They can <em>only </em>reproduce within another cell by taking over that cell. An antibiotic would have to be able to kill human cells to kill a virus, and that would not be a good medicine to take. Viruses invade a host cell and incorporate the virus DNA into the host cell's DNA, which would cause the host cell to create more viruses to invade other cells. <span />
Answer :
Surfactant deficiency due to undeveloped lungs (in premature infants) suggest respiratory distress in an infant, but would be less likely to be observed in an adult beacuse in adults , lungs are fully developed and lack of surfactant is less.
Explanation:
Respiratory distress syndrome is a type of neonatal disease of respiration ,caused by deficiency of the surfactant produced by type II alveolar cells in the lungs most commonly in premature infants.
Normally , the lungs of the fetus start the formation of the surfactant during the third trimester (26 weeks through labor and delivery ) but in the premature infants , the lungs are not totally developed , hence lack of surfactant production results in the respiratory distress syndrome charactarized by inflammation of the airways due to the lack of the surface tension lowring effect of the surfactant.
Answer:
The bacteria with the mutation will survive.
Explanation:
In this population, if there is a group of bacteria of the same specie that mutate and this mutation is the expression of antibiotic resistance, this mean that the "mutant bacteria" are going to live spite the action of the drug.
Meanwhile the rest of the population is going to die because these group of living things are susceptible to the antibiotic, that means, they are going to die.
In the other hand, the "mutant" living things, by passing the time are going to reproduce and lead a new generation of bacteria resistant to the antibiotic.
